These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2436537)

  • 21. CSF monoamine metabolites in chronic schizophrenic patients who attempt suicide.
    Roy A; Ninan P; Mazonson A; Pickar D; Van Kammen D; Linnoila M; Paul SM
    Psychol Med; 1985 May; 15(2):335-40. PubMed ID: 2410941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CSF metabolites in borderline personality disorder compared with normal controls.
    Gardner DL; Lucas PB; Cowdry RW
    Biol Psychiatry; 1990 Aug; 28(3):247-54. PubMed ID: 1696137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study.
    Roy A; De Jong J; Linnoila M
    Arch Gen Psychiatry; 1989 Jul; 46(7):609-12. PubMed ID: 2472124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels.
    Placidi GP; Oquendo MA; Malone KM; Huang YY; Ellis SP; Mann JJ
    Biol Psychiatry; 2001 Nov; 50(10):783-91. PubMed ID: 11720697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attempted suicide characteristics and cerebrospinal fluid amine metabolites in depressed inpatients.
    Mann JJ; Malone KM; Sweeney JA; Brown RP; Linnoila M; Stanley B; Stanley M
    Neuropsychopharmacology; 1996 Dec; 15(6):576-86. PubMed ID: 8946432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes of cerebrospinal fluid monoamine metabolites during long-term antidepressant treatment.
    Bäckman J; Alling C; Alsén M; Regnéll G; Träskman-Bendz L
    Eur Neuropsychopharmacol; 2000 Sep; 10(5):341-9. PubMed ID: 10974605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid monoamine metabolites in boys with attention-deficit hyperactivity disorder.
    Castellanos FX; Elia J; Kruesi MJ; Gulotta CS; Mefford IN; Potter WZ; Ritchie GF; Rapoport JL
    Psychiatry Res; 1994 Jun; 52(3):305-16. PubMed ID: 7527565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of neurotransmitter in forensic medicine (report II). A simple and simultaneous analysis of the major monoamine metabolites in human cerebrospinal fluid by high performance liquid chromatography with electrochemical detection.
    Endo T; Nishida A; Kano S
    Nihon Hoigaku Zasshi; 1987 Feb; 41(1):4-9. PubMed ID: 2439728
    [No Abstract]   [Full Text] [Related]  

  • 30. CSF monoamine metabolites in melancholia.
    Asberg M; Bertilsson L; Mårtensson B; Scalia-Tomba GP; Thorén P; Träskman-Bendz L
    Acta Psychiatr Scand; 1984 Mar; 69(3):201-19. PubMed ID: 6201041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aggression and personality: association with amino acids and monoamine metabolites.
    Møller SE; Mortensen EL; Breum L; Alling C; Larsen OG; Bøge-Rasmussen T; Jensen C; Bennicke K
    Psychol Med; 1996 Mar; 26(2):323-31. PubMed ID: 8685288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biogenic amines in seasonal affective disorder: effects of light therapy.
    Rudorfer MV; Skwerer RG; Rosenthal NE
    Psychiatry Res; 1993 Jan; 46(1):19-28. PubMed ID: 7681996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aggression in humans correlates with cerebrospinal fluid amine metabolites.
    Brown GL; Goodwin FK; Ballenger JC; Goyer PF; Major LF
    Psychiatry Res; 1979 Oct; 1(2):131-9. PubMed ID: 95232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are monoamine metabolites in cerebrospinal fluid worth measuring?
    Potter WZ; Manji HK
    Arch Gen Psychiatry; 1993 Aug; 50(8):653-6. PubMed ID: 7688211
    [No Abstract]   [Full Text] [Related]  

  • 35. CSF amine metabolites and depression.
    Peabody CA; Faull KF; King RJ; Whiteford HA; Barchas JD; Berger PA
    Psychiatry Res; 1987 May; 21(1):1-7. PubMed ID: 2440071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aminergic studies and cerebrospinal fluid cations in suicide.
    Banki CM; Arató M; Kilts CD
    Ann N Y Acad Sci; 1986; 487():221-30. PubMed ID: 2436535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CSF 5-HIAA predicts suicide risk after attempted suicide.
    Nordström P; Samuelsson M; Asberg M; Träskman-Bendz L; Aberg-Wistedt A; Nordin C; Bertilsson L
    Suicide Life Threat Behav; 1994; 24(1):1-9. PubMed ID: 7515519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal fluid monoamine metabolites and atmospheric pressure.
    Heilig M; Månsson JE; Blennow K
    Biol Psychiatry; 1996 Feb; 39(4):299-301. PubMed ID: 8645778
    [No Abstract]   [Full Text] [Related]  

  • 39. CSF 5-HIAA and HVA concentrations in elderly depressed patients who attempted suicide.
    Jones JS; Stanley B; Mann JJ; Frances AJ; Guido JR; Traskman-Bendz L; Winchel R; Brown RP; Stanley M
    Am J Psychiatry; 1990 Sep; 147(9):1225-7. PubMed ID: 1696794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The neurobiology of suicide risk: a review for the clinician.
    Mann JJ; Oquendo M; Underwood MD; Arango V
    J Clin Psychiatry; 1999; 60 Suppl 2():7-11; discussion 18-20, 113-6. PubMed ID: 10073382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.